Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ARCT compared with BLSH: revenue, margins and what each company keeps, and the suppliers and customers both name
ARCT
Arcturus Therapeutics Holdings Inc.
Change
Mkt cap
Revenue
Revenue
BLSH
Bullish
Change
Mkt cap
Revenue
Revenue
vs
Compare
ARCT
Arcturus Therapeutics Holdings Inc.
vs
BLSH
Bullish
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
ARCT
Arcturus Therapeutics Holdings Inc.
Change
10.02
▼
−9.16%
Mkt cap
$313.5M
Revenue
$3M
Q2 FY26
Revenue
$82M
FY25
BLSH
Bullish
Change
23.77
▼
−0.53%
Regular session
Nov 2 '26
Mkt cap
$3.6B
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 2 '26
ARCT
Arcturus Therapeutics Holdings Inc.
vs
BLSH
Bullish
10.02
▼
−9.16%
Price
23.77
▼
−0.53%
$313.5M
Mkt cap
$3.6B
Q2 FY26
$3M
Revenue
—
FY25
$82M
Revenue
—
Change
Change
ARCT
10.02
▼
−9.16%
vs
BLSH
23.77
▼
−0.53%
Regular session
Nov 2 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
ARCT: latest quarter is a loss; flow not drawable. BLSH: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ARCT
3
—
Biomedical Advanced Research and Development Authority (BARDA)
unlisted
customer
—
CSL Seqirus
unlisted
customer
—
Meiji Seika Pharma
unlisted
customer
Shared
0
No shared counterparties.
Only BLSH
4
—
Deloitte & Touche LLP
unlisted
supplier
—
BitGo
unlisted
supplier
—
Fireblocks
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
SPV KY
unlisted
supplier
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ARCT, solid
BLSH, dashed